Stay updated on Capmatinib & Spartalizumab vs Docetaxel in NSCLC Clinical Trial

Sign up to get notified when there's something new on the Capmatinib & Spartalizumab vs Docetaxel in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Capmatinib & Spartalizumab vs Docetaxel in NSCLC Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    Change Detected
    Summary
    The record history now shows the current page revision as v3.6.5, replacing the previous v3.6.4. This is a metadata update indicating the page was refreshed to the latest version.
    Difference
    0.1%
    Check dated 2026-08-08T09:56:44.000Z thumbnail image
  4. Check
    22 days ago
    No Change Detected
  5. Check
    29 days ago
    Change Detected
    Summary
    A new revision entry (v3.6.4) was added to the history, representing an update to the study record. The previous revision (v3.6.3) was removed from the change log.
    Difference
    0.1%
    Check dated 2026-07-25T06:23:23.000Z thumbnail image
  6. Check
    51 days ago
    Change Detected
    Summary
    A new revision entry (v3.6.3) was added to the history, and the previous revision (v3.6.2) was removed from the current listing, updating the page's version history.
    Difference
    0.1%
    Check dated 2026-07-03T21:50:44.000Z thumbnail image
  7. Check
    58 days ago
    Change Detected
    Summary
    A new revision entry v3.6.2 was added to the history, and the previous entry v3.6.0 was removed, updating the study's submission record.
    Difference
    0.1%
    Check dated 2026-06-26T23:09:40.000Z thumbnail image
  8. Check
    72 days ago
    Change Detected
    Summary
    The history now shows recruitment status updated to no longer looking for participants and a new Revision: v3.6.0 added, replacing the previous Revision: v3.5.5.
    Difference
    0.3%
    Check dated 2026-06-12T13:37:30.000Z thumbnail image
  9. Check
    79 days ago
    Change Detected
    Summary
    A new revision entry v3.5.5 appears in the study record history, and the previous revision v3.5.4 is no longer listed. This change updates the history log metadata for the record.
    Difference
    0.1%
    Check dated 2026-06-05T08:46:37.000Z thumbnail image

Stay in the know with updates to Capmatinib & Spartalizumab vs Docetaxel in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Capmatinib & Spartalizumab vs Docetaxel in NSCLC Clinical Trial page.